Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

[Summary] 免疫治疗原创新药研发商

泽安生物医药(LTZ Therapeutics)是一家聚焦新型免疫疗法的全球一体化生物技术公司。针对癌症、自身免疫性疾病等领域的重大未满足临床需求,公司自主研发“髓系细胞衔接器”技术平台(Myeloid Engager Platform)和相关原创新药,旨在提升广大患者的综合临床获益。公司的国际化团队分布于中国深圳、美国加州红木城和德国海德堡。基于反向转化科学与新兴的肿瘤微环境生物学,LTZ致力于开发既能克服耐药、又能增强抗肿瘤免疫力的新一代免疫疗法。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

LTZ/泽安生物 Financing History (6 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3800万美元
  • Investor: 高瓴创投,博裕资本,五源资...

LTZ/泽安生物 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

LTZ/泽安生物 Related Industry Tags

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 475万(美元)
Legal Representative: Jinze Li
Date Established:
Credit Code: 91440300MA5H7EMU34
Registered Address: 深圳市南山区粤海街道高新区社区高新南九道39号深圳清华大学研究院新大楼B3004

People who follow LTZ/泽安生物 also follow

LTZ/泽安生物 Competitors (Similar Companies)

肿瘤检测 临床医学 临床研究 医学检验所
“中国第三方检测与认证服务的开拓者和领先者”
“一家致力于中成药、化学药及生物制品的研发、生产、销售及售后服务的医药集团”
“呼吸系统吸入给药配方技术及装置研发、生产、销售”
产后修复 光学 医疗器械 健康管理
“关爱大众健康,共创美好生活”
“抗肿瘤和精神类药物研发和生产,中国医药工业前30强”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

月子中心(非医疗机构)
客服
由百度提供